AS WARRANT AGENT FORM OF PREFERRED STOCK WARRANT AGREEMENT DATED AS OFPreferred Stock Warrant Agreement • March 30th, 2022 • Bolt Biotherapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMarch 30th, 2022 Company Industry JurisdictionTHIS PREFERRED STOCK WARRANT AGREEMENT (this “Agreement”), dated as of [•], between BOLT BIOTHERAPEUTICS, INC., a Delaware corporation (the “Company”), and [•], a [corporation] [national banking association] organized and existing under the laws of [•] and having a corporate trust office in [•], as warrant agent (the “Warrant Agent”).
BOLT BIOTHERAPEUTICS, INC. AND , AS WARRANT AGENT FORM OF DEBT SECURITIES WARRANT AGREEMENT DATED AS OF BOLT BIOTHERAPEUTICS, INC. FORM OF DEBT SECURITIES WARRANT AGREEMENTWarrant Agreement • March 30th, 2022 • Bolt Biotherapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMarch 30th, 2022 Company Industry JurisdictionTHIS DEBT SECURITIES WARRANT AGREEMENT (this “Agreement”), dated as of [•], between BOLT BIOTHERAPEUTICS, INC., a Delaware corporation (the “Company”), and [•], a [corporation] [national banking association] organized and existing under the laws of [•] and having a corporate trust office in [•], as warrant agent (the “Warrant Agent”).
BOLT BIOTHERAPEUTICS, INC. COMMON STOCK SALES AGREEMENTSales Agreement • March 30th, 2022 • Bolt Biotherapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMarch 30th, 2022 Company Industry JurisdictionBolt Biotherapeutics, Inc. (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows:
AS WARRANT AGENT FORM OF COMMON STOCK WARRANT AGREEMENT DATED As OF ____________ BOLT BIOTHERAPEUTICS, INC. FORM OF COMMON STOCK WARRANT AGREEMENTWarrant Agreement • March 30th, 2022 • Bolt Biotherapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMarch 30th, 2022 Company Industry JurisdictionTHIS COMMON STOCK WARRANT AGREEMENT (this “Agreement”), dated as of [•], between BOLT BIOTHERAPEUTICS, INC., a Delaware corporation (the “Company”), and [•], a [corporation] [national banking association] organized and existing under the laws of [•] and having a corporate trust office in [•], as warrant agent (the “Warrant Agent”).